Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells.

[1]  Yen-Ling Chen,et al.  Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. , 2008, European journal of pharmacology.

[2]  N. Bousette,et al.  Urotensin-II and cardiovascular remodeling , 2008, Peptides.

[3]  H. Inoue,et al.  Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligands , 2008, Cancer science.

[4]  Chieh-Hsi Wu,et al.  Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. , 2007, European journal of pharmacology.

[5]  N. Bousette,et al.  Urotensin-II and cardiovascular diseases , 2006, Current hypertension reports.

[6]  Yen-Ling Chen,et al.  Reactive Oxygen Species Generation Is Involved in Epidermal Growth Factor Receptor Transactivation through the Transient Oxidization of Src Homology 2-Containing Tyrosine Phosphatase in Endothelin-1 Signaling Pathway in Rat Cardiac Fibroblasts , 2006, Molecular Pharmacology.

[7]  S. Douglas,et al.  Expression of urotensin-II in human coronary atherosclerosis , 2005, Peptides.

[8]  S. Douglas,et al.  A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker. , 2005, Journal of molecular and cellular cardiology.

[9]  J. Pfeilschifter,et al.  Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. Mehta,et al.  Human Urotensin II Modulates Collagen Synthesis and the Expression of MMP-1 in Human Endothelial Cells , 2004, Journal of cardiovascular pharmacology.

[11]  R. Hannan,et al.  Urotensin II: the old kid in town , 2004, Trends in Endocrinology & Metabolism.

[12]  Jaung-Geng Lin,et al.  Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. , 2004, Cardiovascular research.

[13]  Toshiyuki Fukada,et al.  Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. , 2002, Molecular cell.

[14]  T. Katagiri,et al.  Synergistic Effect of Urotensin II With Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells , 2001, Circulation.

[15]  J. Bertoglio,et al.  Human Urotensin II–Induced Contraction and Arterial Smooth Muscle Cell Proliferation Are Mediated by RhoA and Rho-Kinase , 2001, Circulation research.

[16]  F. Böhmer,et al.  Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. , 2000, Current medicinal chemistry.

[17]  S. Douglas,et al.  Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. , 2000, Trends in cardiovascular medicine.

[18]  J. Fei,et al.  Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.